Alzheimer's disease (AD) pathology is associated with two proteins, the microtubule-binding protein tau and the ␤-amyloid-precursor protein (APP). When tau becomes hyperphosphorylated, it forms neuritic aggregates, called neurofibrillary tangles. APP is cleaved by several enzymes to generate A␤ peptides, which are -depending on their length -more or less amyloidogenic and form senile plaques. Pin1, a peptidyl-propyl cis/trans-isomerase, seems to be involved in both pathologies. Pin1 may facilitate dephosphorylation of tau by PP2A phosphatase, while cellular overexpression of Pin1 causes a reduction in the amyloidogenic processing of APP, making this enzyme an interesting target for pharmaceutical intervention. The gene encoding Pin1 maps to 19p13.2, a region previously linked to late-onset Alzheimer's disease (LOAD). Therefore, Pin1 is an excellent positional and functional candidate for LOAD. In this study, we investigated whether common single nucleotide polymorphisms (SNPs) in Pin1 can influence the risk for developing late-onset Alzheimer's disease. No association was observed with any of six polymorphisms or their resulting haplotypes. A meta-analysis of two promoter SNPs, which combined the data from this study with two previous ones, did not show any association either suggesting that common SNPs in Pin1 do not increase the risk for LOAD.
Pin1 is a prototypic member of the family of peptidyl-prolyl isomerases. These enzymes catalyze the cis-trans isomerization of peptide bonds N-terminal to specific phospho-Ser/Thr-Pro motifs. Alzheimer's disease (AD) pathology is defined by the presence of two deposits: senile plaques, formed by ␤-amyloid peptide (A␤) and neurofibrillary tangles, which are aggregates of hyperphosphorylated tau protein.
Pin 1 binds to tau phosphorylated on pThr231-Pro and induces conformational changes, which dephosphorylate tau and restore its biological function [4] . Pin1 also regulates ␤-amyloid-precursor protein (APP) processing. Pastorino et al. [7] showed that Pin1 controls APP isomerization at the phosphory-lated Thr668-Pro motif, which affects the processing of APP into neurotrophic or toxic cleavage products. Pin1 overexpression reduces A␤ secretion from cell cultures, while knockout of Pin1 increases Aß secretion. In Pin1 −/− mice, there is an agedependent increase in insoluble Aß42 in the brain [7] . Pin1 also regulates cell-cycle control, cell proliferation and apoptosis and has been linked to risk for certain types of cancer [3] .
A region on chromosome 19 has recently been associated with late-onset Alzheimer's disease (LOAD) independently of the apolipoprotein E gene [10] . The gene encoding Pin1 maps to 19p13.2, which makes Pin1 an excellent positional and functional candidate for AD.
To test whether common variants in Pin1 are a risk factor for LOAD, we genotyped six single nucleotide polymorphisms (SNPs). These SNPs were tagging SNPs chosen from Hapmap (http://www.hapmap.org) or -as in the case of rs2233678 (-842G/C) and rs2233679 (-667C/T) -were used in two previous studies testing Pin1 promoter polymorphisms for their association with AD [1, 9] . Segat et al. [9] found an association with -842G/C and with a haplotype of the two SNPs. In contrast, Lambert et al. [1] failed to detect association between these polymorphisms or haplotypes in a large French case-control series. In another Italian study, in which AD cases and controls were screened for sequence variations in Pin1, only rare variations were found, which had no effect on the genetic risk for AD [8] .
We used Sequenom TM technology to genotype the Pin1 SNPs in a Caucasian LOAD case-control series from the WashU-ADRC and a case-control series generated by selecting one case per family from our genetic linkage sample [6] and matched controls, also recruited from the WashU-ADRC. The combined sample consists of 750 cases and 658 healthy controls. For the cases, a clinical diagnosis of probable or definite dementia of the Alzheimer's type was made using the NINCDS-ADRDA or similar criteria with minimum age of onset of 60 years [5] . The cases have an average age-of-onset of 75 ± 6.8 years (range 58-99 years) while the average age at last assessment for the controls is 77.1 ± 8.9 years (range 60-104 years). The controls are 60% women and the cases are 69% women. All studies were approved by the Washington University School of Medicine Human Studies Committee and informed consent was obtained from all the subjects.
The primers for the Sequenom genotyping are summarized in Table 1. APOE genotyping was performed following the protocol on the Pyrosequencing TM website (http://www.pyrosequencing. com/pages/assay register clin gen.html). The combined casecontrol series had an expected APOE ε4 allele distribution. Using the program STRUCTURE, we found no evidence of population stratification among the WashU-ADRC case-control data set [2] . Chi square tests were used to test for deviation from Hardy-Weinberg equilibrium and to test for allelic association. A Fisher's exact test was used for the genotypic tests and to stratify for presence or absence of the APOE4 ε4 allele. Odds ratios and 95% confidence intervals were calculated Table 1 Sequenom primers for the six Pin1 SNPs for allelic associations and haplotypes. Linkage disequilibrium (LD) analysis was carried out on a pair-wise basis for all the SNPs in the control sample using the Haploview program (http://www.broad.mit.edu/mpg/haploview/index.php). The distribution of allele and genotype frequencies of the six SNPs is shown in Table 2 . The frequencies of all SNPs were in Hardy-Weinberg equilibrium in cases and controls. We found no differences in the allelic or genotypic frequencies between cases and controls for any of the six SNPs (Table 2 ) even after stratifying for presence or absence of the APOE ε4 allele (data not shown). The SNPs cover the region of the Pin1 gene, which is 14 kb in size, and around 4 kb 5 of the first exon of Pin1. All the SNPs were in strong LD (Fig. 1) . Haplotypes formed by the tagging SNPs from Haploview (rs2287839, rs1077220, rs2010457 and rs2287838) did not show any significant association (global p-value 0.4251). The three-SNP haplotype including rs1077220, rs2010457 and rs2287838 resulted in a p-value of 0.7555. One SNP (rs2287839) was dropped because inclusion of this SNP resulted in a rare haplotype.
With this study, we confirmed the results from [1] . They studied the two promoter SNPs, rs2233678 and rs2233679, for their potential to influence the risk of developing LOAD in a large French case-control population. Their data suggested that these two Pin1 SNPs didn't make a significant contribution to AD risk. This finding was in contrast to an earlier study from [9] . We combined the data from our study and the two previous studies in a meta-analysis, which resulted in a p-value of 0.55 for the genotypic and a p-value of 0.60 for the allelic test with rs223678 and in a p-value of 0.98 for the genotypic test and a p-value of 0.84 for the allelic test with rs223679.
We also sequenced the four exons and approximately 100 bp in the adjacent introns of Pin1 in 45 individuals. We confirmed the known SNP in exon 2 (rs2233682). We found two SNPs in intron 2 (rs2233683 and a rare polymorphism at chromosome position 9810393 (C/T, freq = 2%)) and rs2010457, which we had already genotyped. In our study, none of the six common SNPs in Pin1, including the two promoter SNPs, rs223678 and rs223679, was associated with increased LOAD risk. Our study was designed to test whether common variation in Pin1 explains any risk for AD. Therefore, we cannot rule out the possibility that rare variants in Pin1, that increase Pin1 expression, might influence the risk for LOAD since this type of association would not be detected by a method that relies on linkage disequilibrium.
